IndraLab

Statements


USP10 inhibits AKT. 12 / 12
| 12

reach
"To our attention, USP10 was also found to suppress the AKT/mTOR signaling pathway by inhibiting PTEN, but the underlying mechanisms are controversial."

reach
"Another study showed that USP10 inhibits the AKT/mTOR signaling but does not provide sufficient data on PTEN stability in hepatocellular carcinoma cells (33)."

reach
"In the present study, we screened a panel of Dubs to identify novel modulators on PTEN/AKT/mTOR signaling and found that USP10 suppresses AKT activation."

reach
"In agreement with this finding, depletion of USP10 by sgRNA triggered the activation of AKT/mTOR signaling (Fig. 5E)."

reach
"In addition, USP10 inhibited the activation of AKT/mTOR signaling (Lu et al. 2018)."

reach
"USP10 suppresses ABCG2-induced malignant characteristics of doxorubicin-resistant thyroid cancer by inhibiting PI3K/AKT pathway."

reach
"USP10 is lowly expressed in NSCLC cells and suppresses the activation of the AKT/mTOR signaling pathway."

reach
"USP10 was reported to inhibit tumor growth and inactivate mTORC1 and AKT signaling by stabilizing AMPKalpha and PTEN in HCC cells."

reach
"Mechanistic studies demonstrated that USP10 suppresses the activation of the AKT/mTOR pathway via decreasing the K63-linked polyubiquitination of PTEN, which resulted in the inhibition of the cell viability, proliferation, and migration of the A549 and H1299 NSCLC cell lines."

reach
"The activation of the AKT/mTOR pathway was confirmed in TGF-β1-induced HLF, and USP10 overexpression inhibited AKT/mTOR activation (Fig. S1F, G)."

reach
"These data thus demonstrated that USP10 might activate PTEN, thus inhibiting the AKT/mTOR signaling pathway."

reach
"Mechanistically, overexpressing USP10 inhibited PI3K/AKT pathway by activating PTEN."